DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 115 filers reported holding DENALI THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $144 | +278.9% | 6,293 | +355.4% | 0.00% | – |
| Q4 2022 | $38 | -100.0% | 1,382 | -59.9% | 0.00% | – |
| Q3 2022 | $105,000 | -74.9% | 3,450 | -63.2% | 0.00% | – |
| Q4 2021 | $418,000 | +1572.0% | 9,376 | +1988.2% | 0.00% | – |
| Q1 2021 | $25,000 | – | 449 | +454.3% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 81 | -96.9% | 0.00% | – |
| Q1 2020 | $45,000 | -63.4% | 2,603 | -63.4% | 0.00% | – |
| Q4 2019 | $123,000 | +3.4% | 7,115 | -9.0% | 0.00% | – |
| Q3 2019 | $119,000 | +5850.0% | 7,815 | +6412.5% | 0.00% | – |
| Q2 2019 | $2,000 | -83.3% | 120 | -77.9% | 0.00% | – |
| Q1 2019 | $12,000 | -50.0% | 543 | -51.3% | 0.00% | – |
| Q3 2018 | $24,000 | – | 1,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $339,037,000 | 35.95% |
| Euclidean Capital LLC | 323,749 | $27,117,000 | 5.74% |
| Flagship Pioneering Inc. | 2,730,263 | $228,687,000 | 4.16% |
| Casdin Capital, LLC | 1,310,000 | $109,726,000 | 3.25% |
| A.R.T. Advisors, LLC | 6,173 | $517,000 | 2.39% |
| MARK ASSET MANAGEMENT LP | 172,040 | $14,410,000 | 1.73% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $369,420,000 | 1.59% |
| Integral Health Asset Management, LLC | 57,500 | $4,816,000 | 1.43% |
| GILDER GAGNON HOWE & CO LLC | 3,219,843 | $269,694,000 | 1.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,365 | $1,622,000 | 0.95% |